Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

October 2022; Volume 42,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Agocs, GAËLLE RHYNER

    1. Open Access
      Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma – MORSECRC
      ARMIN GERGER, WOLFGANG EISTERER, STEFAN FUXIUS, SARA BASTIAN, DIETER KOEBERLE, MANFRED WELSLAU, DILARA AKHOUNDOVA SANOYAN, CHRISTIAN MAAS, JENS UHLIG, KLAUS FENCHEL, RICHARD GREIL, EYCK VON DER HEYDE, GAËLLE RHYNER AGOCS, RUDOLF WEIDE, MONIKA SCHWAGER, FRANK REICHENBACH, DOMINIK PAUL MODEST and RALPH FRITSCH
      Anticancer Research October 2022, 42 (10) 4773-4785; DOI: https://doi.org/10.21873/anticanres.15982
  2. Akahane, TAKEMI

    1. You have access
      Leaky Gut and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Lenvatinib
      YUKI FUJIMOTO, TADASHI NAMISAKI, SOICHI TAKEDA, KOJI MURATA, MASAHIDE ENOMOTO, HIROAKI TAKAYA, YUKI TSUJI, YUKIHISA FUJINAGA, YASUHIKO SAWADA, NORIHISA NISHIMURA, KOH KITAGAWA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, KEI MORIYA, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
      Anticancer Research October 2022, 42 (10) 4895-4905; DOI: https://doi.org/10.21873/anticanres.15995
  3. Aoki, YOICHI

    1. You have access
      Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy
      SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI
      Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
  4. Arai, FUMIHITO

    1. You have access
      Simultaneous Detection and HER2 Profiling of Circulating Breast Cancer Cells in Clinical Patients Using a Rare Cell Sorter
      TOMOKO MORI, ATSUKO FURUKAWA, TURAN BILAL, AYA UEDA, HIROKO BANDO, TAISUKE MASUDA, FUMIHITO ARAI and SATOSHI MATSUSAKA
      Anticancer Research October 2022, 42 (10) 4879-4886; DOI: https://doi.org/10.21873/anticanres.15993
  5. Arakaki, YOSHIHISA

    1. You have access
      Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy
      SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI
      Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
  6. Ariga, TAKURO

    1. You have access
      Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy
      SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI
      Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
  7. Armstrong, BRUCE K.

    1. Open Access
      Cutaneous Melanoma: Sheep in Wolves Clothing?
      FRANK R. DE GRUIJL and BRUCE K. ARMSTRONG
      Anticancer Research October 2022, 42 (10) 5021-5025; DOI: https://doi.org/10.21873/anticanres.16010
  8. Asaoka, MARIKO

    1. You have access
      β-Tubulin Isoforms Related to Docetaxel Sensitivity in 2D and 3D Cultured TNBC Cell Lines
      MASAKO MUGURUMA, MARIKO ASAOKA, SAEKO TERAOKA, KANA MIYAHARA, TAKAHIKO KAWATE and TAKASHI ISHIKAWA
      Anticancer Research October 2022, 42 (10) 4735-4742; DOI: https://doi.org/10.21873/anticanres.15978
  9. Atake, YUSA

    1. You have access
      Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors
      HARUKA KANAOKA, MASAYUKI NAGAHASHI, YUSA ATAKE, AKIRA HATTORI, AYAKO BUN, REIKO FUKUI, HIROMI OZAWA, YUKIE FUJIMOTO, TOMOKO HIGUCHI, KEIKO NATORI, MICHIKO IMAMURA, KEIKO MURASE, YUICHI TAKATSUKA and YASUO MIYOSHI
      Anticancer Research October 2022, 42 (10) 4867-4878; DOI: https://doi.org/10.21873/anticanres.15992
  10. Avallone, ANTONIO

    1. Open Access
      Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy
      ANTONIO AVALLONE, SABRINA BIMONTE, CLAUDIA CARDONE, MARCO CASCELLA and ARTURO CUOMO
      Anticancer Research October 2022, 42 (10) 4667-4678; DOI: https://doi.org/10.21873/anticanres.15971
« Previous (Pages : 1 2 3 4 5 6 ... 37) Next »
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (10)
Anticancer Research
Vol. 42, Issue 10
October 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Recombinant Thrombomodulin Has Anti-tumor Effects and Enhances the Effects of Gemcitabine for Pancreatic Cancer Through G-protein Coupled Receptor 15
  • Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma – MORSECRC
  • Surgical Administration of Indocyanine Green in Hepatectomy for Improved Bile Leakage Detection
  • Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain Radiotherapy
  • An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act!
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire